7-Bromo-2-methyl-2,3-dihydropyrazolo[5,1-b]oxazole, 97%, 1g

3,4,5-trihydroxybenzoic acid, 98.00%, 100g

3-Bromo-4-ethoxybenzaldehyde, 95.0%, 5g

3-(Dimethylamino)-1-(1,3-oxazol-2-yl)prop-2-en-1-one, 97.0%, 5g

2-((5-Chloroquinolin-8-yl)oxy)-N,N-diethylethanamine dihydrochloride, 98.0%, 50mg

Dispensing pipette Ripette®, violet, 1 piece

methanesulfonic acid; methyl 2-imino-3-methyl-2,3-dihydro-1,3-benzothiazole-6-carboxylate, 95.0%, 250mg

5-Chlorothiophene-2-sulfonamide, 98.0%, 100g

3,4,5-Trimethoxybenzonitrile, 95%, 25g

(R)-2-((2-(1H-Pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-2-methyl-N-(2,2,2-trifluoroethyl)butanamide, 95.0%, 5mg

1-(3,6-Dimethoxy-2-nitrophenyl)ethanone, 95.0%, 250mg

4-Chloro-7-methoxyquinazolin-6-yl acetate hydrochloride, 95%, 50mg

Pyrazolo[1,5-a]pyridin-6-amine, 98%, 100mg